Key Highlights of the Report: Worldwide Growing Cases of Cancer: The growing incidence and prevalence of cancer are the major factors for increasing the demand for plasmid DNA manufacturing. Increased Government Support: The regulatory environment is becoming conducive to the approval of gene therapies and Advanced Therapy Medicinal Products (ATMP), which is fueling capital and innovation in...